BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zelber-Sagi S, Shoham D, Zvibel I, Abu-Abeid S, Shibolet O, Fishman S. Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. World J Hepatol 2017; 9(2): 91-98 [PMID: 28144390 DOI: 10.4254/wjh.v9.i2.91]
URL: https://www.wjgnet.com/1948-5182/full/v9/i2/91.htm
Number Citing Articles
1
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2020; 32(3): 420 doi: 10.1097/MEG.0000000000001519
2
Michelle L. Aktary, Lindsay K. Eller, Alissa C. Nicolucci, Raylene A. Reimer. Cross-sectional analysis of the health profile and dietary intake of a sample of Canadian adults diagnosed with non-alcoholic fatty liver diseaseFood & Nutrition Research 2020; 64(0) doi: 10.29219/fnr.v64.4548
3
Yoonjin Nam, Sung Kwon Ko, Uy Dong Sohn. Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation modelJournal of Ginseng Research 2019; 43(4): 606 doi: 10.1016/j.jgr.2018.07.007
4
Guangya Chen, Yi Lv, Wei Ni, Qingxin Shi, Xingliang Xiang, Sen Li, Chengwu Song, Mingzhong Xiao, Shuna Jin. Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight PopulationCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8888405
5
Oksana S. Khukhlina, Oksana D. Liakhovych, Ludmila V. Kaniovska, Olena V. Kaushanska, Alona A. Antoniv, Vera O. Shuper. FEATURES OF SOME ANTHROPOMETRIC INDICES AND INDICES OF INSULIN RESISTANCE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS ON THE BACKGROUND OF OBESITY AND OSTEOARTHRITISWiadomości Lekarskie 2020; 73(4): 746 doi: 10.36740/WLek202004123
6
Cristina M. Muzica, Catalin Sfarti, Anca Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Carol Stanciu, Branka Filipović. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional RelationshipCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/6638306
7
Flavio A. Cadegiani. Dietary Interventions in Liver Disease2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
8
Chun Kit Hung, Henry C. Bodenheimer. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisClinics in Liver Disease 2018; 22(1): 175 doi: 10.1016/j.cld.2017.08.012
9
Kara Wegermann, Ricardo Henao, Anna Mae Diehl, Susan K. Murphy, Manal F. Abdelmalek, Cynthia A. Moylan, Pavel Strnad. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot studyPLOS ONE 2018; 13(9): e0204308 doi: 10.1371/journal.pone.0204308
10
Diego Meneses, Antonio Olveira, Ramon Corripio, María del Carmen Méndez, Míriam Romero, Isabel Calvo-Viñuelas, Lucrecia Herranz, David Vicent, Ana Isabel de-Cos-Blanco. Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different ThresholdsObesity Surgery 2020; 30(7): 2538 doi: 10.1007/s11695-020-04509-0